Native interoperability
FHIR R4, HL7 and European standards from design — sovereign connectors, not legacy silos.
Vision & Market
A thesis built on data precision
The European HealthTech market remains fragmented. Azuro Health occupies the rare space between product execution and institutional rigour.
- €45b
- EU HealthTech market by 2028
- 9
- Complementary Business Units
- 100%
- In-house execution
- 48h
- Investor response
Market context
European digital health players face a dual constraint: exponential clinical data growth and rising interoperability (EHDS, FHIR) and sovereignty requirements. Generalist solutions struggle to combine HDS compliance, product velocity and operational resilience.
Azuro Health addresses this gap through an integrated model — engineering, security and deployment — within a technology holding already structured for multi-sector execution.
The three pillars of the thesis
Structural holding advantage
Shared engineering, cybersecurity (Azuro Consulting) and sector capabilities to reduce marginal cost.
Institutional execution
Platforms sized for investment committees, medical leadership and B2B partners.